InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Novel Ingredients in Infant Formula Market”-, By Product Type (Plant-Based Milk, Plant-Based Juices, RTD Tea & Coffee, Others), By Source (Nuts, Grains, Legumes, Fruits & Vegetables, Others), By Distribution Channel (Online, Offline), and Global Forecasts, 2024-2034 And Segment Revenue and Forecast To 2034.”
Novel Ingredients in Infant Formula Market Size is predicted to grow at 8.7% CAGR during the forecast period for 2025-2034.
Check this Report Brochure : https://www.insightaceanalytic.com/request-sample/2977
The term “novel ingredients” in infant formula refers to bioactive components that extend beyond conventional nutrients such as proteins, fats, carbohydrates, vitamins, and minerals. These advanced ingredients are incorporated to more accurately emulate the composition and functional benefits of human breast milk. One of the most prominent examples is Milk Fat Globule Membrane (MFGM), a biologically complex, tri-layered membrane that encapsulates fat globules in breast milk. MFGM is rich in critical bioactive compounds, including phospholipids, cholesterol, and proteins such as lactoferrin and osteopontin. Current research suggests that these elements contribute meaningfully to neurological development, cognitive performance, and immune function in infants. Recent technological advancements in extraction and preservation have enabled the inclusion of MFGM in commercial infant formulas.
In parallel, the addition of novel prebiotics—non-digestible food components that selectively support the growth of beneficial gut microbiota—is becoming increasingly common. Galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS) are among the most widely used prebiotics, known to promote gut health and overall infant well-being.
There is a rising consumer demand for infant formulas fortified with functional ingredients that address critical aspects of early childhood development, including immunity, digestion, and brain function. This trend is particularly evident in the specialty formula segment, which targets the specific nutritional and health needs of infants with unique dietary requirements. The incorporation of prebiotics, probiotics, and postbiotics reflects a broader emphasis on establishing and maintaining a robust gut microbiome, which is foundational to immune health.
Concurrently, innovations in biotechnology have facilitated the production of sophisticated ingredients such as human milk oligosaccharides (HMOs) and MFGM, both of which closely replicate key components of breast milk. These scientific advancements are significantly enhancing the nutritional profile and functional performance of next-generation infant formula products, positioning them as more effective alternatives for infant nutrition where breastfeeding is not possible.
List of Prominent Players in the Novel Ingredients in Infant Formula Market:
- DSM
- FrieslandCampina
- Novonesis (Chr. Hansen + Novozymes)
- DuPont (IFF Nutrition)
- BASF
- AAK
- Glycosyn
- Inbiose
- Kyowa Hakko
- Nestlé
- Danone (Nutricia)
- Abbott Nutrition
- Reckitt (Mead Johnson)
- Arla Foods
- Fonterra
- Helaina
- Biomilq
- 108LABS
- Turtletree Labs
- Else Nutrition
- ByHeart
- Sprout Organic
- Conagen
- Nature’s One
- Bactolife
- Evonik
- Glycotope
Market Dynamics:
Drivers:
The increasing focus on infant health and nutrition serves as a primary catalyst for the growing adoption of novel ingredients in the infant formula market. Today’s consumers are more health-conscious and informed, leading to heightened demand for premium-quality formulas enriched with advanced components such as human milk oligosaccharides (HMOs), milk fat globule membrane (MFGM), and bioengineered proteins. These ingredients are recognized for their roles in supporting immunity, digestive health, and cognitive development. Additionally, the rising incidence of food allergies, gastrointestinal disorders, and metabolic conditions among infants has accelerated the need for specialized, hypoallergenic formulas. In response, manufacturers are significantly investing in research and development to create innovative formulations that align with evolving nutritional requirements and growing consumer expectations for high-performance infant nutrition solutions.
Challenges:
Despite the promising growth trajectory, the market faces notable challenges. Chief among these is the complex and time-intensive regulatory approval process required for novel ingredients, which must meet stringent safety and efficacy standards before being integrated into infant nutrition products. Moreover, the development of these ingredients involves high research and development expenditures and requires specialized manufacturing infrastructure, which can pose financial and operational constraints, particularly for smaller players in the industry.
Regional Trends:
The Asia-Pacific region continues to lead the global infant formula market, fueled by high birth rates, rapid urbanization, and increasing household incomes. In particular, China represents a significant growth driver, bolstered by an expanding retail landscape and policy shifts such as the relaxation of the one-child policy. However, the country’s recent demographic transition—characterized by declining birth rates and an aging population—is prompting domestic dairy producers to broaden their portfolios by including adult nutrition offerings.
In contrast, North America holds a prominent position within the infant formula ingredients market, supported by favorable government policies and a strong focus on pediatric nutrition. The regional market is defined by a rising preference for organic, non-GMO, and clean-label products, reflecting consumer priorities centered on quality, safety, and transparent sourcing practices. These regional dynamics collectively shape the evolving landscape of novel ingredient adoption in infant nutrition globally.
Recent Developments:
- In April 2025, DSM-Firmenich received approval from the FSSAI to use GLYCARE 2FL, a human milk oligosaccharide, in early-life nutrition products in India. This comes after the European Commission recently approved dsm-firmenich’s HMO ingredient, LNFP-I. The company also just introduced Dry Vit A Palmitate, an early-life nutraceutical intended to treat vitamin A deficiency. Infants can now use the component 2′-O-Fucosyllactose (2′-FL), with a daily maximum suggested intake of 1.2 grams per liter of formula.
- In Oct 2024, dsm-firmenich, Launched Dry Vit A Palmitate for Early Life Nutrition, a ground-breaking clean-label solution created to improve the nutritional value of newborn formulae without the stability problems associated with conventional vitamin A components, was announced by leaders in health, nutrition, and beauty.
- In Sep 2023, Danone, the head of Danone’s early life nutrition division and vice president announced a new newborn formula in China that contains milk droplets that closely resemble the structure of mothers’ milk, according to Growth Asia.
Segmentation of Novel Ingredients in Infant Formula Market.
Global Novel Ingredients in Infant Formula Market – By Ingredient Type
- Human Milk Oligosaccharides (HMOs)
- Milk Fat Globule Membrane (MFGM)
- Synthetic/Bioengineered Proteins
- Next-Gen Probiotics
- Plant-Based Bioactives
- Glycomacropeptides (GMPs)
- Exosomes and MicroRNAs
Global Novel Ingredients in Infant Formula Market – By Application
- Standard Infant Formula
- Follow-On Formula
- Specialty Formula
- Growing-Up Milk
Global Novel Ingredients in Infant Formula Market – By Source
- Bioengineered
- Plant-Based
- Animal-Derived
Global Novel Ingredients in Infant Formula Market – By Region
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
